• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Aelius Biotech

To add a bio or update company history, please click update information.

News from Aelius Biotech

    Aelius Biotech raises £750k from Mercia Ventures to expand lab-grown digestion model internationallyAelius Biotech raises £750k from Mercia Ventures to expand lab-grown digestion model internationally
    Aelius Biotech
    7 Apr 2025

    Aelius Biotech raises £750k from Mercia Ventures to expand lab-grown digestion model internationally

    Aelius Biotech runs a laboratory based digestion model that simulates how substances are absorbed by the human gut, helping food and pharmaceutical companies test products without animal trials.

Aelius Biotech
  • Life Sciences
  • Newcastle, United Kingdom
  • £750k
  • aeliusbiotech.co.uk
  • Update Information

More venture news

  • Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
    Imperagen
    21 May 2026

    Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering

    SeedLife Sciences
  • Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments
    Infex Therapeutic
    12 May 2026

    Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments

    EquityLife Sciences
  • Scarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases
    Scarlet Therapeutics
    11 May 2026

    Scarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn